Redefining Prospective Research: Using Data Networks for Pharmacovigilance and Post-Marketing Surveillance



Dear Colleague,

Automated data networks are transforming prospective research by adding value in ways not possible with traditional registries.

This webinar challenges the status quo and explores innovative approaches to building and leveraging data networks.

headshots_RG-1Join Dr. Richard Gliklich, CEO of OM1, as he explores:

  • Comparing traditional prospective research with the newer data network approach
  • Applying real-world data for pharmacovigilance
  • Making data regulatory-grade for submissions and post-marketing commitments
  • Case examples in immunology, dermatology, cardiometabolic, and ENT

 Thursday, March 18, 11:30 - 12:30 EDT


**Please be advised this webinar series is intended primarily for biopharmaceutical and medical device companies. Due to the proprietary nature of the content, all registrations are at the discretion of OM1. Vendors and consultants will not be permitted to attend.


This email was sent on behalf of the sponsor by HealthEconomics.Com, 1327 Walnut, Jacksonville, FL, 32206.
If you don't wish to receive further Industry Leaders News Updates from us, you may immediately unsubscribe from this list here, or send your request in writing to the address above.
Read more about our privacy policy here. You may also request a copy in writing using the address above.

To ensure you continue to receive emails from HealthEconomics.Com, please click here.